Matches in SemOpenAlex for { <https://semopenalex.org/work/W4361813534> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W4361813534 abstract "<div>Abstract<p>Imatinib is used to treat chronic myelogenous leukemia (CML), but resistance develops in all phases of this disease. The purpose of the present study was to identify the mode of resistance of newly derived imatinib-resistant (IM-R) and PD166326-resistant (PD-R) CML cells. IM-R and PD-R clones exhibited an increase in viability and a decrease in caspase activation in response to various doses of imatinib and PD166326, respectively, as compared with parental K562 cells. Resistance involved neither mutations in BCR-ABL nor increased BCR-ABL, MDR1 or Lyn expression, all known modes of resistance. To gain insight into the resistance mechanisms, we used pangenomic microarrays and identified 281 genes modulated in parental versus IM-R and PD-R cells. The gene signature was similar for IM-R and PD-R cells, accordingly with the cross-sensitivity observed for both inhibitors. These genes were functionally associated with pathways linked to development, cell adhesion, cell growth, and the JAK-STAT cascade. Especially relevant were the increased expression of the tyrosine kinases AXL and Fyn as well as CD44 and HMGA2. Small interfering RNA experiments and pharmacologic approaches identified FYN as a candidate for resistance to imatinib. Our findings provide a comprehensive picture of the transcriptional events associated with imatinib and PD166326 resistance and identify Fyn as a new potential target for therapeutic intervention in CML. [Mol Cancer Ther 2009;8(7):1924–33]</p></div>" @default.
- W4361813534 created "2023-04-05" @default.
- W4361813534 creator A5012912804 @default.
- W4361813534 creator A5019765162 @default.
- W4361813534 creator A5021986215 @default.
- W4361813534 creator A5022811994 @default.
- W4361813534 creator A5034528977 @default.
- W4361813534 creator A5037025946 @default.
- W4361813534 creator A5038903944 @default.
- W4361813534 creator A5039959145 @default.
- W4361813534 creator A5044327360 @default.
- W4361813534 creator A5074620596 @default.
- W4361813534 creator A5077255086 @default.
- W4361813534 date "2023-03-31" @default.
- W4361813534 modified "2023-09-27" @default.
- W4361813534 title "Data from Gene expression profiling of imatinib and PD166326-resistant CML cell lines identifies Fyn as a gene associated with resistance to BCR-ABL inhibitors" @default.
- W4361813534 doi "https://doi.org/10.1158/1535-7163.c.6531453" @default.
- W4361813534 hasPublicationYear "2023" @default.
- W4361813534 type Work @default.
- W4361813534 citedByCount "0" @default.
- W4361813534 crossrefType "posted-content" @default.
- W4361813534 hasAuthorship W4361813534A5012912804 @default.
- W4361813534 hasAuthorship W4361813534A5019765162 @default.
- W4361813534 hasAuthorship W4361813534A5021986215 @default.
- W4361813534 hasAuthorship W4361813534A5022811994 @default.
- W4361813534 hasAuthorship W4361813534A5034528977 @default.
- W4361813534 hasAuthorship W4361813534A5037025946 @default.
- W4361813534 hasAuthorship W4361813534A5038903944 @default.
- W4361813534 hasAuthorship W4361813534A5039959145 @default.
- W4361813534 hasAuthorship W4361813534A5044327360 @default.
- W4361813534 hasAuthorship W4361813534A5074620596 @default.
- W4361813534 hasAuthorship W4361813534A5077255086 @default.
- W4361813534 hasBestOaLocation W43618135342 @default.
- W4361813534 hasConcept C175818844 @default.
- W4361813534 hasConcept C2776960273 @default.
- W4361813534 hasConcept C2777413986 @default.
- W4361813534 hasConcept C2777583451 @default.
- W4361813534 hasConcept C2778461978 @default.
- W4361813534 hasConcept C2778729363 @default.
- W4361813534 hasConcept C2779536868 @default.
- W4361813534 hasConcept C3019892230 @default.
- W4361813534 hasConcept C37686147 @default.
- W4361813534 hasConcept C42362537 @default.
- W4361813534 hasConcept C502942594 @default.
- W4361813534 hasConcept C54355233 @default.
- W4361813534 hasConcept C62478195 @default.
- W4361813534 hasConcept C86803240 @default.
- W4361813534 hasConceptScore W4361813534C175818844 @default.
- W4361813534 hasConceptScore W4361813534C2776960273 @default.
- W4361813534 hasConceptScore W4361813534C2777413986 @default.
- W4361813534 hasConceptScore W4361813534C2777583451 @default.
- W4361813534 hasConceptScore W4361813534C2778461978 @default.
- W4361813534 hasConceptScore W4361813534C2778729363 @default.
- W4361813534 hasConceptScore W4361813534C2779536868 @default.
- W4361813534 hasConceptScore W4361813534C3019892230 @default.
- W4361813534 hasConceptScore W4361813534C37686147 @default.
- W4361813534 hasConceptScore W4361813534C42362537 @default.
- W4361813534 hasConceptScore W4361813534C502942594 @default.
- W4361813534 hasConceptScore W4361813534C54355233 @default.
- W4361813534 hasConceptScore W4361813534C62478195 @default.
- W4361813534 hasConceptScore W4361813534C86803240 @default.
- W4361813534 hasLocation W43618135341 @default.
- W4361813534 hasLocation W43618135342 @default.
- W4361813534 hasOpenAccess W4361813534 @default.
- W4361813534 hasPrimaryLocation W43618135341 @default.
- W4361813534 hasRelatedWork W2051451579 @default.
- W4361813534 hasRelatedWork W2100041900 @default.
- W4361813534 hasRelatedWork W2108689358 @default.
- W4361813534 hasRelatedWork W2122132017 @default.
- W4361813534 hasRelatedWork W2552820660 @default.
- W4361813534 hasRelatedWork W2556047608 @default.
- W4361813534 hasRelatedWork W2572120445 @default.
- W4361813534 hasRelatedWork W2979743675 @default.
- W4361813534 hasRelatedWork W4361813510 @default.
- W4361813534 hasRelatedWork W4361813534 @default.
- W4361813534 isParatext "false" @default.
- W4361813534 isRetracted "false" @default.
- W4361813534 workType "article" @default.